Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: Clin Cancer Res. 2013 May 29;19(14):4008–4016. doi: 10.1158/1078-0432.CCR-13-0033

Figure 3.

Figure 3

Pre- and Post- Vorinostat Values of Proliferation-Associated Gene Expression using the Oncotype DX® 21-gene assay.

Vorinostat-Treated Women (+, N=14) versus Control (○, N=11) for Ki-67 (A), STK15 (B), MYBL2 (C), Cyclin B1 (D), Survivin (E), and the Proliferation Axis (F). Values are on a log2 scale. Exact two-sided p-values are based upon the 2-sample Wilcoxon rank-sum test.